Gilfillan A, Warner J P, Kirk J M, Marshall T, Greening A, Ho L P, Hargreave T, Stack B, McIntyre D, Davidson R, Dean J C, Middleton W, Brock D J
Human Genetics Unit, University of Edinburgh, Western General Hospital, UK.
J Med Genet. 1998 Feb;35(2):122-5. doi: 10.1136/jmg.35.2.122.
Only three mutant cystic fibrosis (CF) alleles have to date been established as conferring a dominant mild effect on affected subjects who are compound heterozygotes. We now add a fourth, P67L, which occurs on about 1.4% of Scottish CF chromosomes. Among 13 patients (12 unrelated) with this allele, the average age at diagnosis was 22.5 +/- 11.3 years. None of the cases had consistently raised sweat chloride concentrations, the average value being 57 +/- 9 mmol/l; 77% of the patients were pancreatic sufficient. When compared to three other established mild CF alleles, R117H, A455E, and 3849 + 10kb C-T, a compound heterozygote for P67L has minimal disease and clinical suspicions are unlikely to be confirmed other than by DNA typing.
迄今为止,只有三种突变的囊性纤维化(CF)等位基因被证实对复合杂合子的患病个体具有显性轻度影响。我们现在又发现了第四种,即P67L,它出现在约1.4%的苏格兰CF染色体上。在13名携带此等位基因的患者(12名无亲缘关系)中,诊断时的平均年龄为22.5±11.3岁。所有病例的汗液氯化物浓度均未持续升高,平均值为57±9 mmol/l;77%的患者胰腺功能正常。与其他三种已确定的轻度CF等位基因R117H、A455E和3849 + 10kb C-T相比,P67L的复合杂合子疾病程度最轻,除了通过DNA分型外,临床怀疑不太可能得到证实。